Annexon, Inc.
ANNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001528115
In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Annexon, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- −5 vs. Q1 2023
- Shares held
- 54.1M
- +308.2K (+0.6%) vs. Q1 2023
- Total value
- $190.0M
- −$17.6M (−8.5%) vs. Q1 2023
- New holders
- 27
- 38 more added
- Sold out
- 32
- 18 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $1.02B |
| Q1 2026 | 217 | $863.7M |
| Q4 2025 | 168 | $687.2M |
| Q3 2025 | 144 | $309.2M |
| Q2 2025 | 129 | $238.7M |
| Q1 2025 | 148 | $192.1M |
| Q4 2024 | 153 | $574.6M |
| Q3 2024 | 142 | $651.8M |
| Q2 2024 | 140 | $526.9M |
| Q1 2024 | 127 | $679.4M |
| Q4 2023 | 99 | $365.7M |
| Q3 2023 | 93 | $126.0M |
| Q2 2023 | 95 | $190.0M |
| Q1 2023 | 100 | $207.6M |
| Q4 2022 | 84 | $243.3M |
| Q3 2022 | 72 | $292.3M |
| Q2 2022 | 78 | $144.9M |
| Q1 2022 | 100 | $105.9M |
| Q4 2021 | 97 | $445.7M |
| Q3 2021 | 82 | $708.6M |
| Q2 2021 | 74 | $873.7M |
| Q1 2021 | 72 | $1.04B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Annexon, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 0 | $0 | 0.00% | −464,819−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −461,284−100.0% | Sold out |
| Luminus Management LLC | 0 | $0 | 0.00% | −425,000−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −130,377−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −113,807−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −80,400−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −66,773−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −45,505−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −33,550−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −31,366−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −27,136−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −25,192−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,135−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −16,274−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −14,113−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −12,166−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −12,091−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −11,609−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −11,250−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −10,140−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −5,794−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| WealthPlan Investment Management, LLC | 0 | $0 | 0.00% | −561−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −381−100.0% | Sold out |